Current applications of nanoemulsions in cancer therapeutics.

dc.contributor.authorSánchez-López, E. (Elena)
dc.contributor.authorGuerra, Mariana
dc.contributor.authorDias-Ferreira, João
dc.contributor.authorLópez-Machado, Ana
dc.contributor.authorEttcheto Arriola, Miren
dc.contributor.authorCano Fernández, Amanda
dc.contributor.authorEspina García, Marta
dc.contributor.authorCamins Espuny, Antoni
dc.contributor.authorGarcía, Maria Luisa
dc.contributor.authorSouto, Eliana B.
dc.date.accessioned2019-07-12T11:36:59Z
dc.date.available2019-07-12T11:36:59Z
dc.date.issued2019-05-31
dc.date.updated2019-07-12T11:36:59Z
dc.description.abstractNanoemulsions are pharmaceutical formulations composed of particles within a nanometer range. They possess the capacity to encapsulate drugs that are poorly water soluble due to their hydrophobic core nature. Additionally, they are also composed of safe gradient excipients, which makes them a stable and safe option to deliver drugs. Cancer therapy has been an issue for several decades. Drugs developed to treat this disease are not always successful or end up failing, mainly due to low solubility, multidrug resistance (MDR), and unspecific toxicity. Nanoemulsions might be the solution to achieve e cient and safe tumor treatment. These formulations not only solve water-solubility problems but also provide specific targeting to cancer cells and might even be designed to overcome MDR. Nanoemulsions can be modified using ligands of di erent natures to target components present in tumor cells surface or to escape MDR mechanisms. Multifunctional nanoemulsions are being studied by a wide variety of researchers in di erent research areas mainly for the treatment of di erent types of cancer. All of these studies demonstrate that nanoemulsions are e ciently taken by the tumoral cells, reduce tumor growth, eliminate toxicity to healthy cells, and decrease migration of cancer cells to other organs.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec690419
dc.identifier.issn2079-4991
dc.identifier.pmid31159219
dc.identifier.urihttps://hdl.handle.net/2445/137101
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/nano9060821
dc.relation.ispartofNanomaterials, 2019, vol. 9, p. 821
dc.relation.urihttps://doi.org/10.3390/nano9060821
dc.rightscc-by (c) Sánchez-López, E. (Elena) et al., 2019
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)
dc.subject.classificationNanopartícules
dc.subject.classificationCàncer
dc.subject.classificationSistemes d'alliberament de medicaments
dc.subject.classificationFarmacologia experimental
dc.subject.otherNanoparticles
dc.subject.otherCancer
dc.subject.otherDrug delivery systems
dc.subject.otherExperimental pharmacology
dc.titleCurrent applications of nanoemulsions in cancer therapeutics.
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
690419.pdf
Mida:
1.39 MB
Format:
Adobe Portable Document Format